The vaccine showed a 77.8% efficacy against RSV-associated LRTD after the second season.
Pharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.